These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3325801)

  • 1. Complexity of neurotoxicological assessment.
    Sette WF
    Neurotoxicol Teratol; 1987; 9(6):411-6. PubMed ID: 3325801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisions to the FDA's Redbook guidelines for toxicity testing: neurotoxicity.
    Sobotka TJ
    Crit Rev Food Sci Nutr; 1992; 32(2):165-71. PubMed ID: 1515045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotoxicology in regulation and risk assessment.
    Reiter LW
    Dev Pharmacol Ther; 1987; 10(5):354-68. PubMed ID: 3308380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution and current status of neurotoxicity risk assessment.
    Tilson HA
    Drug Metab Rev; 1996; 28(1-2):121-39. PubMed ID: 8744593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Food and Drug Administration Proposed Guidelines for Neurotoxicological Testing of Food Chemicals.
    Sobotka TJ; Ekelman KB; Slikker W; Raffaele K; Hattan DG
    Neurotoxicology; 1996; 17(3-4):825-36. PubMed ID: 9086506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive neurotoxicity assessment.
    Kulig BM
    Environ Health Perspect; 1996 Apr; 104 Suppl 2(Suppl 2):317-22. PubMed ID: 9182038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity, Work Group IV report: triggers for developmental neurotoxicity testing.
    Levine TE; Butcher RE
    Neurotoxicol Teratol; 1990; 12(3):281-4. PubMed ID: 2196426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EPA's neurotoxicity risk assessment guidelines.
    Boyes WK; Dourson ML; Patterson J; Tilson HA; Sette WF; MacPhail RC; Li AA; O'Donoghue JL
    Fundam Appl Toxicol; 1997 Dec; 40(2):175-84. PubMed ID: 9441713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity, Work Group III report: weight of evidence and quantitative evaluation of developmental neurotoxicity data.
    Tyl RW; Sette WF
    Neurotoxicol Teratol; 1990; 12(3):275-80. PubMed ID: 2196425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity, Work Group I report: comparability of measures of developmental neurotoxicity in humans and laboratory animals.
    Stanton ME; Spear LP
    Neurotoxicol Teratol; 1990; 12(3):261-7. PubMed ID: 2115099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability, sensitivity and validity of behavioral indices of neurotoxicity.
    Vorhees CV
    Neurotoxicol Teratol; 1987; 9(6):445-64. PubMed ID: 3325804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Setting exposure standards: a decision process.
    Tilson HA; MacPhail RC; Crofton KM
    Environ Health Perspect; 1996 Apr; 104 Suppl 2(Suppl 2):401-5. PubMed ID: 9182048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk assessment strategies for neuroprotective agents.
    Slikker W; Gaylor DW
    Ann N Y Acad Sci; 1995 Sep; 765():198-208; discussion 209. PubMed ID: 7486606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adoption of new guidelines and data requirements for more extensive neurotoxicity testing under FIFRA.
    Sette WF
    Toxicol Ind Health; 1989 Mar; 5(2):181-94. PubMed ID: 2728014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of learning, memory and attention in developmental neurotoxicity regulatory studies: Introduction.
    Makris SL; Vorhees CV
    Neurotoxicol Teratol; 2015; 52(Pt A):62-7. PubMed ID: 26049062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity, Work Group II report: testing methods in developmental neurotoxicity for use in human risk assessment.
    Buelke-Sam J; Mactutus CF
    Neurotoxicol Teratol; 1990; 12(3):269-74. PubMed ID: 2196424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining neurotoxicity in a decision-making context.
    Tilson HA; MacPhail RC; Crofton KM
    Neurotoxicology; 1995; 16(2):363-75. PubMed ID: 7566695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpretation and application of delayed neurotoxicity test data from regulatory and legal viewpoints: panel discussion.
    Rosenstein LS; Maddy KT; Sette WF; Mendoza CE; Beyer SV
    Neurotoxicology; 1983; 4(4):85-97. PubMed ID: 6686874
    [No Abstract]   [Full Text] [Related]  

  • 19. Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity: summary and implications.
    Francis EZ; Kimmel CA; Rees DC
    Neurotoxicol Teratol; 1990; 12(3):285-92. PubMed ID: 2196427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scientific and regulatory issues relevant to assessing risk for developmental neurotoxicity: an overview.
    Rees DC; Francis EZ; Kimmel CA
    Neurotoxicol Teratol; 1990; 12(3):175-81. PubMed ID: 2196418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.